State of Connecticut

State of Connecticut was paid $205.92M by Medicaid between Jan 2018 and Dec 2024, across 778 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 10% of everything it billed.

33Billing provider infoSTATE OF CONNECTICUT
FARMINGTON, CT 06030

33aNPI1669466561assigned 09/07/2005

33bProvider typeProfessional Counselor

28Total paid$205.92M

24GClaims6,309,714

24DCodes billed778

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Professional Counselor providers in Connecticut

Rank by total paid#1 of 418

Median peer was paid$79K

This provider vs. median2,615×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	803,563	$22.67M
2019	910,795	$25.08M
2020	708,376	$22.35M
2021	996,818	$35.52M
2022	958,633	$34.40M
2023	1,027,937	$35.95M
2024incomplete	903,592	$29.94M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	10%	259,221	198,635	$20.85M
J3357	Ustekinumab, for subcutaneous injection, 1 mg	8.3%	2,197	1,785	$17.13M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	7.0%	102,709	79,050	$14.47M
J2350	Injection, ocrelizumab, 1 mg	6.0%	691	541	$12.25M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.1%	32,930	24,787	$10.48M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.0%	79,293	62,712	$8.27M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	3.2%	28,751	19,292	$6.67M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	2.9%	6,326	1,314	$5.89M
J3241	Injection, teprotumumab-trbw, 10 mg	2.4%	245	83	$4.97M
J0791	Injection, crizanlizumab-tmca, 5 mg	2.2%	1,131	737	$4.43M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.0%	66,820	21,901	$4.08M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.9%	34,901	22,763	$4.00M

766 more codes

J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.7%	2,137	$3.60M
64483		1.7%	5,120	$3.57M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	25,988	$2.91M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	14,497	$2.76M
27447		1.3%	312	$2.63M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	9,656	$2.37M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,432	$1.89M
96361	Intravenous infusion, hydration; each additional hour	<1%	40,727	$1.82M
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	3,520	$1.64M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	11,223	$1.61M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	6,102	$1.60M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,226	$1.59M
27130		<1%	171	$1.55M
41899	Unlisted procedure, dentoalveolar structures	<1%	1,170	$1.36M
99213	Doctor's office visit, returning patient (routine)	<1%	41,050	$1.31M
96375	Therapeutic injection; each additional sequential IV push	<1%	37,933	$1.30M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	10,955	$1.24M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,149	$1.23M
62323		<1%	2,655	$1.22M
71046	Radiologic examination, chest; 2 views	<1%	26,854	$1.22M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	12,807	$1.13M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	20,057	$1.13M
36512		<1%	1,945	$1.12M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,672	$1.12M
99214	Doctor's office visit, returning patient (more involved)	<1%	23,109	$1.11M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	708	$1.07M
J0897	Injection, denosumab, 1 mg	<1%	2,244	$981K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,825	$963K
93975		<1%	5,264	$947K
70450	Computed tomography, head or brain; without contrast material	<1%	11,287	$905K
29848		<1%	725	$806K
86900		<1%	21,495	$805K
J9271	Injection, pembrolizumab, 1 mg	<1%	98	$754K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	28,938	$727K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	8,778	$723K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	28,897	$723K
72110		<1%	9,222	$712K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,575	$694K
62321		<1%	1,345	$667K
97161		<1%	12,188	$621K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	4,153	$593K
81513		<1%	6,567	$588K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,033	$572K
78815	Positron emission tomography (PET) for limited area imaging	<1%	782	$562K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,222	$557K
84443	Thyroid stimulating hormone (TSH)	<1%	58,325	$555K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,511	$546K
90834	Psychotherapy session, about 45 minutes	<1%	18,983	$512K
76830	Ultrasound, transvaginal	<1%	5,821	$501K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,730	$500K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,111	$488K
96415		<1%	7,330	$487K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,811	$479K
G0379	Direct admission of patient for hospital observation care	<1%	581	$465K
20610		<1%	2,445	$459K
11104		<1%	2,656	$453K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,510	$453K
11102		<1%	4,861	$452K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	27,197	$445K
94060		<1%	2,731	$444K
59025	Fetal non-stress test	<1%	3,444	$444K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,188	$430K
72100		<1%	9,127	$429K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	26,683	$424K
J9312	Injection, rituximab, 10 mg	<1%	235	$418K
72141		<1%	2,457	$417K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	11,574	$394K
82947		<1%	142,154	$389K
73221		<1%	2,211	$377K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	5,476	$359K
76536		<1%	5,680	$355K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	19,493	$355K
72050		<1%	4,148	$345K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,787	$336K
22612		<1%	47	$311K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	958	$296K
95911		<1%	848	$291K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	11,125	$289K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	448	$285K
96920		<1%	2,088	$280K
96900		<1%	10,613	$278K
J1628	Injection, guselkumab, 1 mg	<1%	47	$276K
83036	Hemoglobin; glycosylated (A1C)	<1%	46,478	$275K
90792	Psychiatric diagnostic evaluation with medical services	<1%	4,037	$275K
J9310	Injection, rituximab, 100 mg	<1%	101	$262K
71250		<1%	5,245	$258K
36415	Collection of venous blood by venipuncture	<1%	306,317	$253K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	139,632	$252K
83718		<1%	37,677	$247K
71045	Radiologic examination, chest; single view	<1%	7,165	$237K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	10,014	$236K
36430		<1%	2,077	$235K
82310		<1%	122,959	$232K
86803		<1%	24,772	$231K
S9480	Intensive outpatient psychiatric services, per diem	<1%	2,524	$227K
97162		<1%	4,841	$224K
77065	Tomosynthesis, mammo	<1%	2,388	$219K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	35,138	$217K
77080		<1%	3,496	$216K
72040		<1%	4,713	$209K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	18,860	$209K
86480		<1%	8,403	$204K
76770		<1%	2,982	$200K
11100		<1%	1,142	$200K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	30,652	$197K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,006	$193K
76641		<1%	2,929	$193K
97165		<1%	3,013	$191K
17110		<1%	5,157	$190K
93971		<1%	3,409	$190K
11900		<1%	2,963	$182K
93017		<1%	3,075	$174K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	9,005	$168K
74183		<1%	923	$168K
85027		<1%	56,952	$166K
97035		<1%	2,114	$164K
87481		<1%	6,563	$160K
72156		<1%	1,176	$160K
76642		<1%	2,957	$152K
64650		<1%	720	$152K
95806		<1%	1,352	$151K
70496		<1%	2,026	$146K
J2997	Injection, alteplase recombinant, 1 mg	<1%	1,387	$143K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	15,476	$142K
82607		<1%	16,372	$140K
63047		<1%	79	$138K
82728		<1%	21,606	$137K
94010		<1%	3,919	$130K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	18,870	$128K
72197		<1%	504	$128K
86003		<1%	1,936	$122K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	14,686	$117K
93970		<1%	1,101	$116K
86780		<1%	11,268	$116K
36593		<1%	937	$115K
87536		<1%	2,835	$113K
88142		<1%	9,597	$110K
77066	Tomosynthesis, mammo	<1%	1,144	$110K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	58	$110K
77336		<1%	1,734	$104K
64721		<1%	72	$102K
99203	Doctor's office visit, new patient (routine)	<1%	2,070	$101K
58558		<1%	116	$101K
95812		<1%	605	$100K
86235		<1%	4,017	$98K
87340		<1%	17,103	$98K
29888		<1%	19	$98K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	1,138	$96K
72158		<1%	538	$95K
77063	Screening digital breast tomosynthesis, bilateral	<1%	7,271	$94K
17311		<1%	558	$90K
87086	Culture, bacterial; quantitative colony count, urine	<1%	28,791	$90K
97116		<1%	4,265	$89K
88184		<1%	725	$87K
26055		<1%	152	$86K
83550		<1%	21,915	$86K
95708		<1%	269	$84K
70491		<1%	670	$84K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,636	$82K
74018		<1%	2,523	$82K
72082		<1%	1,345	$81K
96417		<1%	2,059	$81K
83970		<1%	6,429	$79K
73564		<1%	2,180	$76K
84132		<1%	135,233	$76K
70486		<1%	1,330	$73K
84439		<1%	16,050	$72K
73700		<1%	1,004	$72K
17000		<1%	5,250	$70K
84153		<1%	6,681	$69K
83540		<1%	22,439	$65K
72070		<1%	1,573	$65K
90832	Psychotherapy session, about 30 minutes	<1%	3,427	$63K
86160		<1%	5,639	$62K
10005		<1%	162	$62K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,176	$62K
84403		<1%	3,815	$61K
96367		<1%	2,830	$61K
86706		<1%	10,389	$59K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	44,452	$59K
82784		<1%	8,265	$58K
95811		<1%	96	$57K
82570		<1%	23,865	$56K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,081	$54K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	14	$54K
64493		<1%	58	$53K
82670		<1%	2,911	$53K
84702		<1%	10,231	$53K
88342		<1%	4,049	$52K
95910		<1%	238	$52K
73130		<1%	4,627	$51K
87510		<1%	3,192	$49K
87480		<1%	3,192	$49K
86762		<1%	5,322	$49K
86147		<1%	1,284	$48K
83516		<1%	6,907	$48K
87660		<1%	3,143	$48K
86038		<1%	7,591	$48K
71271		<1%	629	$48K
86360		<1%	2,387	$47K
72131		<1%	873	$45K
82105		<1%	3,647	$44K
29827		<1%	14	$43K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,363	$42K
95909		<1%	221	$42K
J0517	Injection, benralizumab, 1 mg	<1%	19	$42K
10060		<1%	315	$41K
86140		<1%	17,238	$41K
95700		<1%	481	$41K
77091		<1%	1,137	$41K
73030		<1%	3,975	$40K
82043		<1%	13,507	$40K
84270		<1%	3,181	$40K
82746		<1%	4,952	$39K
76882		<1%	985	$39K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	90	$39K
77386		<1%	135	$38K
84146		<1%	3,144	$36K
90837	Psychotherapy session, about an hour	<1%	1,085	$36K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	944	$36K
82465		<1%	39,854	$36K
83001		<1%	3,016	$36K
86592		<1%	10,624	$34K
82040		<1%	91,473	$34K
87653		<1%	1,311	$34K
88307		<1%	1,737	$34K
86787		<1%	3,934	$33K
87522	Neg quan hep c or qual rna	<1%	1,198	$33K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	2,861	$32K
88304		<1%	4,034	$32K
86704		<1%	5,577	$31K
81001		<1%	17,587	$30K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	163	$30K
86225		<1%	4,194	$30K
83735		<1%	42,257	$30K
87077		<1%	11,636	$30K
95912		<1%	84	$30K
51729		<1%	91	$30K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,198	$29K
84402		<1%	1,932	$29K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	26	$29K
73630		<1%	5,268	$29K
95800		<1%	239	$29K
83020		<1%	6,247	$28K
76801		<1%	317	$28K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	537	$28K
93976		<1%	334	$26K
73502		<1%	2,399	$26K
82533		<1%	4,979	$25K
78306		<1%	137	$25K
84165		<1%	6,561	$25K
85652		<1%	20,914	$25K
83002		<1%	2,161	$25K
86618		<1%	3,387	$25K
82274		<1%	2,066	$25K
87186		<1%	9,403	$24K
93225		<1%	485	$24K
J2357	Injection, omalizumab, 5 mg	<1%	26	$24K
82565		<1%	165,196	$23K
43235		<1%	49	$23K
86146		<1%	883	$23K
90686		<1%	1,954	$23K
95819		<1%	165	$23K
86800		<1%	3,474	$22K
72146		<1%	163	$22K
97016		<1%	557	$22K
74220		<1%	219	$22K
86141		<1%	4,252	$22K
82747		<1%	2,379	$21K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,617	$21K
86376		<1%	2,963	$20K
86334		<1%	3,369	$20K
99215	Doctor's office visit, returning patient (complex)	<1%	241	$20K
85610		<1%	22,656	$20K
86039		<1%	3,500	$20K
84481		<1%	1,997	$19K
80061	Lipid panel	<1%	8,034	$19K
20680		<1%	28	$19K
83655		<1%	1,819	$19K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	942	$18K
82247		<1%	77,425	$18K
82088		<1%	1,454	$17K
82024		<1%	1,907	$17K
83880		<1%	7,260	$17K
73110		<1%	1,789	$17K
86850		<1%	19,839	$17K
87338		<1%	1,481	$17K
77334		<1%	75	$16K
82627		<1%	1,246	$16K
93296		<1%	1,131	$16K
94726		<1%	393	$15K
86200		<1%	2,631	$15K
84480		<1%	2,500	$15K
76857		<1%	277	$15K
88112		<1%	1,145	$15K
86705		<1%	3,100	$15K
73610		<1%	3,095	$15K
81003		<1%	48,541	$15K
80053	Comprehensive metabolic panel	<1%	20,942	$14K
86359		<1%	2,388	$14K
82652		<1%	644	$14K
76000		<1%	99	$14K
84154		<1%	1,167	$14K
84425		<1%	1,129	$14K
86430		<1%	4,823	$14K
74178		<1%	67	$13K
82785		<1%	1,628	$13K
87070		<1%	7,707	$12K
76981		<1%	1,340	$12K
90677		<1%	108	$12K
70546		<1%	27	$12K
83520		<1%	2,206	$12K
83690		<1%	19,281	$12K
82523		<1%	1,843	$12K
82950		<1%	2,957	$12K
84156		<1%	8,812	$11K
73562		<1%	683	$11K
86708		<1%	1,423	$11K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,085	$11K
74019		<1%	477	$11K
86765		<1%	1,151	$11K
72170		<1%	1,273	$11K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	45	$10K
82550		<1%	10,057	$10K
70498		<1%	1,509	$10K
84080		<1%	2,034	$10K
86162		<1%	1,008	$10K
73200		<1%	151	$10K
84244		<1%	1,373	$10K
80048	Basic metabolic panel (calcium, ionized)	<1%	23,323	$10K
J0185	Injection, aprepitant, 1 mg	<1%	64	$10K
85730		<1%	5,213	$9K
96401		<1%	495	$9K
92611		<1%	83	$9K
86617		<1%	1,100	$9K
86735		<1%	955	$9K
86256		<1%	1,336	$9K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	25	$9K
96910		<1%	330	$9K
84295		<1%	134,804	$9K
77062		<1%	749	$9K
64415		<1%	79	$9K
83883		<1%	952	$8K
86304		<1%	1,985	$8K
87529		<1%	245	$8K
72157		<1%	52	$8K
84166		<1%	1,258	$8K
77061		<1%	713	$8K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	797	$8K
86902		<1%	5,677	$8K
13132		<1%	115	$8K
83525		<1%	914	$8K
51702		<1%	1,165	$7K
87081		<1%	2,828	$7K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	4,485	$7K
97535	Self-care/home management training, each 15 minutes	<1%	243	$7K
70544		<1%	14	$7K
51798		<1%	2,051	$7K
85018		<1%	8,050	$7K
85014		<1%	8,822	$7K
84450		<1%	96,113	$7K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	668	$7K
51784		<1%	101	$7K
74230		<1%	83	$7K
12032		<1%	102	$7K
96133		<1%	111	$7K
87625		<1%	289	$7K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	23	$6K
98968		<1%	122	$6K
86255		<1%	1,003	$6K
10022		<1%	18	$6K
85613		<1%	1,265	$6K
29823		<1%	16	$6K
94660		<1%	151	$6K
99443		<1%	579	$6K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,979	$6K
83921		<1%	669	$6K
99204	Doctor's office visit, new patient (more involved)	<1%	78	$6K
62328		<1%	14	$6K
84478		<1%	39,936	$6K
36591		<1%	1,663	$5K
84207		<1%	368	$5K
89230		<1%	116	$5K
83835		<1%	868	$5K
93308		<1%	49	$5K
82340		<1%	2,193	$5K
86694		<1%	446	$5K
87205		<1%	5,966	$5K
84432		<1%	1,051	$5K
86335		<1%	456	$5K
73560		<1%	3,855	$5K
73080		<1%	833	$5K
84445		<1%	200	$4K
78264		<1%	18	$4K
87631		<1%	1,035	$4K
86364		<1%	503	$4K
93270		<1%	486	$4K
81025		<1%	22,640	$4K
96411		<1%	107	$4K
80164		<1%	696	$4K
87147		<1%	1,943	$4K
84144		<1%	221	$4K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	18	$4K
82150		<1%	977	$4K
82248		<1%	42,031	$3K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	7,222	$3K
85007		<1%	8,841	$3K
99442		<1%	278	$3K
86880		<1%	131	$3K
93786		<1%	55	$3K
73590		<1%	798	$3K
84300		<1%	1,706	$3K
83721		<1%	2,219	$3K
95924		<1%	17	$3K
95816		<1%	16	$3K
86757		<1%	238	$3K
81015		<1%	26,396	$3K
93297		<1%	267	$3K
82103		<1%	399	$3K
82378		<1%	1,627	$3K
81050		<1%	1,698	$3K
98967		<1%	57	$3K
11721		<1%	180	$3K
95249		<1%	90	$3K
82390		<1%	371	$2K
85045		<1%	9,098	$2K
88173		<1%	1,003	$2K
90694		<1%	478	$2K
87641		<1%	109	$2K
64642		<1%	18	$2K
87640		<1%	122	$2K
97163		<1%	40	$2K
96116		<1%	50	$2K
80051		<1%	4,270	$2K
82164		<1%	323	$2K
76604		<1%	550	$2K
82330		<1%	5,991	$2K
93280		<1%	262	$2K
85379		<1%	3,897	$2K
84155		<1%	76,857	$2K
87075		<1%	2,158	$2K
87469		<1%	175	$2K
87015		<1%	1,381	$2K
96132		<1%	52	$2K
80177		<1%	262	$2K
87468		<1%	171	$2K
84460		<1%	98,187	$2K
87484		<1%	171	$2K
93298		<1%	191	$2K
73521		<1%	53	$2K
86696		<1%	114	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	27	$2K
80076		<1%	2,538	$2K
74181		<1%	15	$2K
83615		<1%	16,714	$2K
87046		<1%	365	$2K
11301		<1%	55	$2K
82977		<1%	3,067	$2K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	29	$2K
84550		<1%	6,037	$2K
97166		<1%	45	$2K
84540		<1%	840	$2K
87045		<1%	365	$2K
86258		<1%	171	$1K
82525		<1%	293	$1K
87517		<1%	66	$1K
87449		<1%	367	$1K
93285		<1%	54	$1K
86769		<1%	41	$1K
70480		<1%	13	$1K
84520		<1%	151,581	$1K
83498		<1%	76	$1K
93923		<1%	16	$1K
88312		<1%	2,344	$1K
83993		<1%	103	$1K
90662		<1%	178	$1K
84484		<1%	20,812	$1K
77073		<1%	16	$1K
87324		<1%	296	$1K
93880		<1%	19	$1K
73140		<1%	354	$1K
86695		<1%	114	$1K
86666		<1%	121	$1K
84075		<1%	79,478	$1K
76775		<1%	387	$1K
90732		<1%	29	$1K
96137		<1%	19	$1K
72202		<1%	27	$1K
87209		<1%	149	$1K
84305		<1%	175	$992.67
99441		<1%	185	$971.36
82085		<1%	250	$937.62
93299		<1%	44	$877.52
92610		<1%	14	$843.60
87040		<1%	3,452	$835.98
85660		<1%	5,362	$792.13
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	146	$791.36
82962		<1%	23,528	$763.88
96136		<1%	49	$761.07
87177		<1%	149	$723.17
G0378	Hospital observation service, per hour	<1%	12,249	$711.36
87116		<1%	583	$702.68
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	7,358	$701.86
84436		<1%	238	$695.36
64447		<1%	78	$665.29
83519		<1%	47	$641.25
80069		<1%	1,001	$632.67
83605		<1%	8,013	$591.12
76870		<1%	140	$574.04
87807		<1%	324	$571.01
87207		<1%	431	$554.98
84100		<1%	25,361	$554.03
86709		<1%	111	$546.29
96523		<1%	37	$535.91
96402		<1%	52	$534.26
87252		<1%	36	$527.66
82232		<1%	258	$523.62
82374		<1%	132,241	$510.91
87102		<1%	600	$499.95
86753		<1%	39	$489.75
84630		<1%	118	$489.15
86923		<1%	4,318	$488.29
82951		<1%	51	$479.31
94727		<1%	4,581	$431.64
G0008	Administration of influenza virus vaccine	<1%	980	$424.20
82438		<1%	128	$412.23
82010		<1%	1,244	$408.38
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,385	$406.44
86308		<1%	521	$397.06
84446		<1%	49	$395.09
84133		<1%	266	$388.83
82435		<1%	132,555	$382.62
88302		<1%	43	$368.64
86036		<1%	72	$358.87
73060		<1%	19	$358.24
S0028	Injection, famotidine, 20 mg	<1%	858	$352.00
J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	<1%	74	$337.05
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	64	$325.04
74455		<1%	47	$301.73
86901		<1%	21,499	$287.29
84681		<1%	26	$281.53
97164		<1%	40	$277.86
94618		<1%	13	$257.29
76377		<1%	791	$239.02
71101		<1%	34	$233.08
83010		<1%	124	$214.92
82140		<1%	95	$209.90
11901		<1%	12	$186.17
82239		<1%	13	$179.96
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	13,727	$179.61
82803		<1%	1,485	$171.59
86677		<1%	17	$170.45
87206		<1%	594	$167.56
86645		<1%	18	$160.90
85049		<1%	106	$160.82
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	5,049	$160.73
82530		<1%	13	$159.60
95012		<1%	178	$159.42
82575		<1%	30	$153.34
86644		<1%	19	$151.25
87107		<1%	20	$147.90
82952		<1%	45	$130.90
86431		<1%	57	$126.60
89051		<1%	124	$124.32
51701		<1%	187	$122.89
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	27,349	$122.69
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	131	$105.77
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	592	$102.00
90715		<1%	1,020	$101.37
82787		<1%	12	$93.29
73090		<1%	45	$89.56
85240		<1%	18	$85.50
85705		<1%	14	$84.35
84560		<1%	37	$80.37
96376		<1%	13,988	$77.16
80178		<1%	51	$74.93
85008		<1%	2,968	$72.84
G0001		<1%	477	$69.81
82553		<1%	44	$66.12
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	585	$65.62
J1836	Injection, metronidazole, 10 mg	<1%	705	$64.01
82985		<1%	12	$58.81
82308		<1%	15	$51.16
J7120	Ringers lactate infusion, up to 1000 cc	<1%	31,387	$47.72
86593		<1%	13	$46.20
82610		<1%	14	$38.94
94729		<1%	5,384	$38.72
73501		<1%	14	$36.70
84105		<1%	17	$34.58
J0736	Injection, clindamycin phosphate, 300 mg	<1%	209	$25.30
J1650	Injection, enoxaparin sodium, 10 mg	<1%	4,925	$24.10
87181		<1%	71	$23.49
J7030	Infusion, normal saline solution , 1000 cc	<1%	26,701	$22.89
85048		<1%	14	$21.78
84145		<1%	2,521	$21.77
86300		<1%	38	$19.87
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	28,997	$19.69
83935		<1%	18	$19.53
83930		<1%	30	$18.93
J2704	Injection, propofol, 10 mg	<1%	33,816	$18.85
J3490	Unclassified drugs	<1%	390,026	$15.52
J2598	Injection, vasopressin, 1 unit	<1%	23	$15.44
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,360	$15.41
88313		<1%	239	$13.44
J0687	Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg	<1%	227	$11.72
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	38,318	$9.93
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,605	$7.05
A9270	Non-covered item or service	<1%	10,605	$7.00
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	19,312	$6.65
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,789	$6.63
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	419	$6.28
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	28,327	$5.58
J7050	Infusion, normal saline solution, 250 cc	<1%	9,216	$5.10
90656		<1%	45	$4.45
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	6,114	$3.18
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,159	$2.94
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	987	$2.86
J2060	Injection, lorazepam, 2 mg	<1%	1,916	$2.83
J1170	Injection, hydromorphone, up to 4 mg	<1%	20,185	$2.76
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,104	$2.75
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	972	$2.62
J1630	Injection, haloperidol, up to 5 mg	<1%	3,365	$2.01
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	1,485	$1.98
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	7,480	$1.98
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,968	$1.94
A9585	Injection, gadobutrol, 0.1 ml	<1%	12,448	$1.87
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	25,106	$1.63
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	460	$1.60
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,715	$1.05
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	409	$0.96
J1644	Injection, heparin sodium, per 1000 units	<1%	13,014	$0.95
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	420	$0.82
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	21,619	$0.71
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	16,070	$0.50
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,212	$0.24
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	23	$0.07
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	20	$0.06
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	22	$0.06
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	19	$0.05
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	17	$0.05
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	19	$0.05
J3590	Unclassified biologics	0%	814	$0.00
C1769	Guide wire	0%	3,941	$0.00
J1815	Injection, insulin, per 5 units	0%	5,767	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	8,025	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	18,278	$0.00
94760		0%	6,820	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	6,613	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	272	$0.00
99153	Mod sedat endo service >5yrs	0%	1,022	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	503	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	501	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	602	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	869	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	1,161	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	1,924	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	354	$0.00
82945		0%	177	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	1,836	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	11,764	$0.00
88185		0%	685	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	1,396	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	732	$0.00
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	0%	311	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	454	$0.00
88341		0%	2,161	$0.00
95886		0%	2,889	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	1,293	$0.00
84157		0%	200	$0.00
96368		0%	648	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	215	$0.00
95885		0%	563	$0.00
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	0%	491	$0.00
J1094	Injection, dexamethasone acetate, 1 mg	0%	2,341	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	2,106	$0.00
C9359	Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc	0%	1,243	$0.00
99402		0%	734	$0.00
51600		0%	77	$0.00
94761		0%	821	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	113	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	2,997	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	154	$0.00
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	0%	201	$0.00
V2632	Posterior chamber intraocular lens	0%	103	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	704	$0.00
51797		0%	69	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	230	$0.00
J9045	Injection, carboplatin, 50 mg	0%	70	$0.00
Q3014	Telehealth originating site facility fee	0%	769	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	1,104	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	1,635	$0.00
17312		0%	108	$0.00
29826		0%	25	$0.00
88311		0%	90	$0.00
22614		0%	66	$0.00
82810		0%	26	$0.00
22842		0%	48	$0.00
64450		0%	16	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	87	$0.00
11302		0%	22	$0.00
73552		0%	16	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	15	$0.00
Q4114	Integra flowable wound matrix, injectable, 1 cc	0%	13	$0.00
12001		0%	12	$0.00
A4648	Tissue marker, implantable, any type, each	0%	14	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	46	$0.00
C1776	Joint device (implantable)	0%	1,794	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	3,760	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	2,913	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	11,922	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	1,556	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	2,152	$0.00
A4649	Surgical supply; miscellaneous	0%	237	$0.00
17003		0%	3,495	$0.00
86922		0%	2,320	$0.00
76942		0%	204	$0.00
77002		0%	1,861	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	882	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	3,199	$0.00
11101		0%	286	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	1,334	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	7,804	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	14,203	$0.00
93226		0%	485	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	19	$0.00
11103		0%	929	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	96	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	4,543	$0.00
99152		0%	1,481	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	499	$0.00
99401		0%	108	$0.00
85347		0%	129	$0.00
88360		0%	98	$0.00
95874		0%	36	$0.00
S0077	Injection, clindamycin phosphate, 300 mg	0%	513	$0.00
20936		0%	124	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	174	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	2,801	$0.00
99001		0%	1,210	$0.00
77003		0%	431	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	292	$0.00
C1758	Catheter, ureteral	0%	49	$0.00
C1729	Catheter, drainage	0%	59	$0.00
51741		0%	73	$0.00
90653		0%	133	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	27	$0.00
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	0%	238	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	212	$0.00
93356		0%	58	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	61	$0.00
20930		0%	140	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	233	$0.00
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	345	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	20	$0.00
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	0%	488	$0.00
22853		0%	16	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	20	$0.00
82042		0%	13	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	268	$0.00
98960		0%	22	$0.00
95923		0%	17	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	129	$0.00
A6402	Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	15	$0.00
C1762	Connective tissue, human (includes fascia lata)	0%	13	$0.00
36600		0%	15	$0.00
11105		0%	44	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGEOGHEGAN, JEFFREY (CHIEF FINANCIAL OFFICER)